Holds 2 active US DMFs and one valid CEP for abacavir, filing since 2008. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 23 markets.
Holds one active US DMF and 2 valid CEPs for abacavir, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 30 markets.
Holds 4 active US DMFs and one valid CEP for abacavir, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds 2 active US DMFs for abacavir, filing since 2010. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF for abacavir, filing since 2012. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds 2 active US DMFs and 2 valid CEPs for abacavir, filing since 2005. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for abacavir, filing since 2005. Its 2025 FDA inspection closed as VAI.
Holds one valid CEP for abacavir, filing since 2026. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for abacavir, filing since 2024. Its 2018 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Abacavir manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free